PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27959383-4	2017	Sorafenib effectively reversed the activation status of mTORC2 induced by metformin and enhanced the suppression of the mTORC1 and MAPK pathway by metformin in HCC cells, which may be responsible for reduced proliferation upon combined treatment.	Sorafenib	0-9	CREB regulated transcription coactivator 2	Mus musculus	56-62	
27959383-5	2017	The metformin and sorafenib combination led to increased impaired proliferation and tumor inhibition of HCC in vitro and in vivo compared to single agent, which was partially bridged by disrupting the mTORC1/mTORC2 feedback loop.	Sorafenib	18-27	CREB regulated transcription coactivator 2	Mus musculus	208-214